Dermata Therapeutics, Inc. (DRMA)
NASDAQ: DRMA · IEX Real-Time Price · USD
1.725
-0.095 (-5.20%)
At close: Jul 19, 2024, 4:00 PM
1.630
-0.095 (-5.52%)
Pre-market: Jul 22, 2024, 6:00 AM EDT
Dermata Therapeutics Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for DRMA.
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for DRMA.
Recommendation Trends
Rating | Dec '22 | Jan '23 | Feb '23 | Mar '23 |
---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 0 |
Buy | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 |
Total | 2 | 2 | 2 | 0 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Maxim Group | Maxim Group | Strong Buy Maintains $240 → $60 | Strong Buy | Maintains | $240 → $60 | +3,377.66% | Mar 23, 2023 |
Brookline Capital | Brookline Capital | Strong Buy Initiates $3,360 | Strong Buy | Initiates | $3,360 | +194,648.74% | Sep 21, 2021 |
Maxim Group | Maxim Group | Strong Buy Initiates $2,160 | Strong Buy | Initiates | $2,160 | +125,095.62% | Sep 14, 2021 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-16.49
from -40.05
EPS Next Year
-4.70
from -16.49
Revenue Forecast
Revenue | 2024 | 2025 | 2026 |
---|---|---|---|
High | n/a | n/a | n/a |
Avg | n/a | n/a | n/a |
Low | n/a | n/a | n/a |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
EPS Forecast
EPS | 2024 | 2025 | 2026 |
---|---|---|---|
High | -16.98 | -4.84 | -3.58 |
Avg | -16.49 | -4.70 | -3.48 |
Low | -15.85 | -4.52 | -3.34 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.